The head of the Food and Drug Administration (FDA) says exploring the therapeutic potential of psychedelics such as psilocybin and ibogaine is a “top priority” for the Trump administration, especially when it comes to helping military veterans grapple with trauma from being sent to fight “unnecessary wars.” There appears to be strong momentum behind the … Continue reading Exploring Psychedelic Medicine Is A ‘Top Priority’ For Trump Administration, FDA Commissioner Says